Chronic intestinal pseudo‐obstruction in children and adults: diagnosis and therapeutic options
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background: Chronic intestinal pseudo‐obstruction (CIPO) represents the most severe form of gastrointestinal dysmotility with debilitating and potentially lethal consequences. Symptoms can be non‐specific, and result in this condition being diagnosed incorrectly or too late with consequences for morbidity and even mortality. Purpose: The present article aims to provide pediatric and adult gastroenterologists with an up to date review about clinical features, diagnosis and therapeutic options for CIPO. Although pediatric and adult CIPO share many clinical aspects distinctive features can be identified. There is no single diagnostic test or pathognomonic finding of CIPO, thus a stepwise approach including radiology, endoscopy, laboratory, manometry, and histopathology should be considered in the diagnostic work‐up. Treatment of patients with CIPO is challenging and requires a multidisciplinary effort with participation of appropriately experienced gastroenterologists, pathologists, dieticians, surgeons, psychologists, and other subspecialists based on the presence of comorbidities. Current treatment options invariably involve surgery and specialized nutritional support, especially in children. Medical therapies are mainly aimed to avoid complications such as sepsis or intestinal bacterial overgrowth and, where possible, restore intestinal propulsion. More efficacious therapeutic options are eagerly awaited for such difficult patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Review article: metoclopramide and tardive dyskinesia
RAO, A. S., & CAMILLERI, M. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04189.x · Cited by 316 · cited 1×
“In addition, metoclopramide has a boxed warning by the Food and Drug Administration due to the risk of tardive dyskinesia.(98) Octreotide, a long-acting analogue of somatostatin, is known to evoke phase III of the MMC in the small intestine of patients with scleroderma-related CIPO.”
BackgroundMadrid, A. M., Hurtado, C., Venegas, M., Cumsille, F., & Defilippi, C. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03636.x · Cited by 158
Cited by
Advances in the diagnosis and classification of gastric and intestinal motility disorders
on behalf of the International Working Group for Disorders of Gastrointestinal Motility and Function, Keller, J., Bassotti, G., Clarke, J., Dinning, P., Fox, M., Grover, M., Hellström, P. M., Ke, M., Layer, P., et al. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2018.7 · Cited by 265
Bharucha, A. E., Kudva, Y. C., & Prichard, D. O. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00161 · Cited by 252
Malagelada, C., Karunaratne, T. B., Accarino, A., Cogliandro, R. F., Landolfi, S., Gori, A., Boschetti, E., Malagelada, J. R., Stanghellini, V., Azpiroz, F., et al. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13219 · Cited by 43
Self-citationPelizzo, G., Calcaterra, V., Villanacci, V., Mura, G. B., & Bassotti, G. (2018) · Turkish Journal of Gastroenterology · doi:10.5152/tjg.2018.17582 · Cited by 12
“However, in adults, either no or subtle histologic alterations in the smooth muscle in patients with MD type 1 have been documented (3).”
Background
Metadata
- Authors
- Di Nardo, G., Di Lorenzo, C., Lauro, A., Stanghellini, V., Thapar, N., Karunaratne, T. B., Volta, U., & De Giorgio, R.
- Venue
- Neurogastroenterology & Motility
- Publisher
- Wiley
- Published
- 2016-09-29
- Volume
- 29
- Issue
- 1
- ISSN
- 1350-1925 (ISSN-L)
- 1365-2982
- OpenAlex
- W2525468837
- Cited by
- 147
- References
- 2
- FWCI
- 14.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.